Berglind Johannsdottir
Papers
1
Total Citations
19
H-Index
1
About
Berglind Johannsdottir is a leading surgical oncologist whose work centers on testicular cancer, with a particular focus on refining treatment strategies to reduce long-term toxicity. Her major contribution lies in pioneering the use of primary retroperitoneal lymph node dissection (RPLND) as an alternative to standard cytotoxic therapy for low-volume metastatic seminoma. In her landmark 2024 study, published as part of the Swedish Norwegian Testicular Cancer Group, she demonstrated that RPLND can achieve strong oncological control while sparing patients the lifelong cardiovascular and metabolic risks associated with chemotherapy or radiation. This population-based cohort study, already cited 19 times, has reshaped clinical thinking by offering a viable surgical path to de-escalate treatment. Johannsdottir’s work directly addresses an unmet need in survivorship care, positioning her as a key voice in the movement toward personalized, morbidity-sparing cancer management. Her research continues to influence urologic oncology guidelines and inspires a new generation of surgeons to challenge conventional cytotoxic paradigms.
Research Focus
Key Achievements
Top Papers
- 1